Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.044 | 0.7 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.036 | 0.7 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |